Frazier Life Sciences Management’s Braveheart Bio BRVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$106M Buy
+5,267,321
New +$139M 2.64% 11

Other funds holding BRVE

Frazier Life Sciences Management's BRVE Position: Q3 2026 in Review

Frazier Life Sciences Management opened a new position in Braveheart Bio (BRVE) in Q3 2026: 5,267,321 shares worth $106M. The stake represents 2.64% of the portfolio and ranks #11 among its holdings.

64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.

  • Frazier Life Sciences Management held 5,267,321 shares of Braveheart Bio worth $106M as of Q3 2026.
  • Braveheart Bio was a new Frazier Life Sciences Management position in Q3 2026.
  • Braveheart Bio made up 2.64% of Frazier Life Sciences Management's portfolio in Q3 2026, its #11 holding.
  • 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.

Based on Frazier Life Sciences Management's 13F filing for Q3 2026, filed 16 Nov 2026.